Health Care: Drugs

Corcept Therapeutics Inc (CORT: NASDAQ)

$2.7 -0.08 | -2.88%
09/18/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.78
52 Week High 4.49
52 Week Low 1.56
Avg. Daily Vol. (Mil) 0.22
Beta (3 year) 1.32
Share Related Items
Mkt Cap (Mil) 281.12
Shares Out (Mil) 101.12
Float (Mil) 53.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.70
Current Ratio 3.00
LT Debt/ Equity 8.01
Total Debt / Equity 10.15
Valuation Ratios
Price Earnings n.a.
Price/Sales 16.53
Price/Book 81.44
Price/Cash Flow -7.20
Per Share Data
Earnings -0.43
Sales 0.17
Book Value 0.03
Cash Flow -0.39
Business Summary
Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.
General Information
149 Commonwealth Drive
Menlo Park, CA 94025
www.corcept.com
Industry : Drugs
Sector: Health Care
Employees: 44
CEO: Joseph K. Belanoff,M.D.
Short Interest
Current Month (Mil) 4.45
Previous Month (Mil) 4.48
Short Interest Ratio (Days) 18.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -98.00
Return on Investments -140.00
Profitability
Gross Margin 97.10
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter